FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W618788750> ?p ?o ?g. }

• W618788750 abstract "Since its discovery in 1988 the powerful vasoconstrictor endothelin-1 (ET-1) has been widely implicated in the pathophysiology of chronic kidney disease (CKD) as well as the cardiovascular disease with which it is associated. ET receptor antagonists have favourable effects in experimental models of these conditions and orally acting antagonists are now licensed for the treatment of pulmonary arterial hypertension. However, there is a paucity of human data regarding the role of ET-1 in CKD. In this thesis, I have therefore explored the utility of ET-1 as a biomarker in CKD, and, using selective ET receptor antagonists, the beneficial renal and cardiovascular effects of ET receptor antagonism in CKD. I have shown that as glomerular filtration rate (GFR) declines plasma ET-1 increases linearly whereas urinary ET-1 shows an exponential increase. Furthermore, urinary ET-1 may be a useful marker of disease activity in patients with lupus nephritis. Its levels are high in those with biopsy-proven active renal inflammation and these fall with treatment. I have shown that in subjects with stable non-diabetic proteinuric CKD, acute selective ETA receptor antagonism reduces blood pressure and arterial stiffness and that these systemic benefits are associated with an increase in renal blood flow and reduction in proteinuria. Importantly, these effects are seen on top of those achieved with maximal therapy with angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers. Following a study confirming unchanged pharmacokinetics in CKD, I have used an oral selective ETA receptor antagonist to show that the reductions in BP, arterial stiffness and proteinuria seen in my acute studies are maintained longer term. This results of this study also suggest that the mechanism for the reduction in proteinuria is haemodynamic and relates to a reduction in GFR and filtration fraction. In summary, these studies suggest that ET-1 may act as a potential biomarker of renal inflammation, and confirm its role in the pathophysiology of the systemic and renal vasoconstriction seen in CKD. They also suggest that selective ETA receptor antagonism may provide a novel therapeutic approach in proteinuric CKD on top of standard therapies. Larger and longer term studies are now warranted to confirm this potential." @default.
• W618788750 created "2016-06-24" @default.
• W618788750 creator A5085998748 @default.
• W618788750 date "2012-06-30" @default.
• W618788750 modified "2023-09-23" @default.
• W618788750 title "Endothelin system & its antagonism in chronic kidney disease" @default.
• W618788750 hasPublicationYear "2012" @default.
• W618788750 type Work @default.
• W618788750 sameAs 618788750 @default.
• W618788750 citedByCount "0" @default.
• W618788750 crossrefType "dissertation" @default.
• W618788750 hasAuthorship W618788750A5085998748 @default.
• W618788750 hasConcept C126322002 @default.
• W618788750 hasConcept C134018914 @default.
• W618788750 hasConcept C142225936 @default.
• W618788750 hasConcept C144980905 @default.
• W618788750 hasConcept C159641895 @default.
• W618788750 hasConcept C170493617 @default.
• W618788750 hasConcept C2778653478 @default.
• W618788750 hasConcept C2780091579 @default.
• W618788750 hasConcept C71924100 @default.
• W618788750 hasConcept C84393581 @default.
• W618788750 hasConcept C98274493 @default.
• W618788750 hasConceptScore W618788750C126322002 @default.
• W618788750 hasConceptScore W618788750C134018914 @default.
• W618788750 hasConceptScore W618788750C142225936 @default.
• W618788750 hasConceptScore W618788750C144980905 @default.
• W618788750 hasConceptScore W618788750C159641895 @default.
• W618788750 hasConceptScore W618788750C170493617 @default.
• W618788750 hasConceptScore W618788750C2778653478 @default.
• W618788750 hasConceptScore W618788750C2780091579 @default.
• W618788750 hasConceptScore W618788750C71924100 @default.
• W618788750 hasConceptScore W618788750C84393581 @default.
• W618788750 hasConceptScore W618788750C98274493 @default.
• W618788750 hasLocation W6187887501 @default.
• W618788750 hasOpenAccess W618788750 @default.
• W618788750 hasPrimaryLocation W6187887501 @default.
• W618788750 hasRelatedWork W1539206659 @default.
• W618788750 hasRelatedWork W1541055912 @default.
• W618788750 hasRelatedWork W1579732520 @default.
• W618788750 hasRelatedWork W161124801 @default.
• W618788750 hasRelatedWork W1887385804 @default.
• W618788750 hasRelatedWork W1894566821 @default.
• W618788750 hasRelatedWork W1991210746 @default.
• W618788750 hasRelatedWork W2012190892 @default.
• W618788750 hasRelatedWork W2088478981 @default.
• W618788750 hasRelatedWork W2116297818 @default.
• W618788750 hasRelatedWork W2137701513 @default.
• W618788750 hasRelatedWork W2163370089 @default.
• W618788750 hasRelatedWork W2168712739 @default.
• W618788750 hasRelatedWork W2768403698 @default.
• W618788750 hasRelatedWork W2972171053 @default.
• W618788750 hasRelatedWork W2995632710 @default.
• W618788750 hasRelatedWork W3012083526 @default.
• W618788750 hasRelatedWork W3212126026 @default.
• W618788750 hasRelatedWork W599211393 @default.
• W618788750 hasRelatedWork W987487382 @default.
• W618788750 isParatext "false" @default.
• W618788750 isRetracted "false" @default.
• W618788750 magId "618788750" @default.
• W618788750 workType "dissertation" @default.